methamphetamine


July 7, 2021

Researcher Finds Challenges in Study Involving Methamphetamine

Linda Haymes

Michael Wilson, M.D., an assistant professor of Emergency Medicine, is studying how methamphetamine affects the human body, particularly how the body responds to stress.

If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.

“Use meth?”


February 20, 2018

Based on UAMS Research, InterveXion Wins Grants, Partners with BioVentures’ Help

Ben Boulden

Misty Stevens demonstrates one of the lab procedures InterveXion uses in the development of the monoclonal antibody it is studying for possible future use in the treatment of methamphetamine addiction.

Feb. 20, 2018 | Truly good ideas like the one around which InterveXion was built have staying power. Since InterveXion was established as a company in 2004, granting agencies and others have continued to value both the company and its mission. BioVentures from the first saw merit in the new treatment for methamphetamine abuse developed…


January 29, 2015

InterveXion Therapeutics, a UAMS Startup, Receives $14.5 Million to Develop Drug Therapies for Methamphetamine Users

Spencer Watson

LITTLE ROCK – A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.


December 19, 2012

InterveXion and UAMS Complete First Drug Tests in Humans for Methamphetamine Addiction

David Robinson

LITTLE ROCK – InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.


First Human Tests of Meth Medication Completed

David Robinson

Dec. 19, 2012 | InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.


May 29, 2012

Anti-Meth Research Earns Student Award

Jon Parham

May 29, 2012 | While no medication exists now for treating addiction to methamphetamine, UAMS graduate student Shraddha Thakkar and colleagues in the Graduate School and College of Medicine are working to change that.